RxDoctor Payments Data

Noah Wichman, PA

Physician Assistant · Durham, NCNPI 1629037858

Payments from drug & device makers

$1,778in general payments, 2019–2025

Across 97 payments — averaging $18.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$348
  • Novo Nordisk$220
  • Lilly USA, LLC$193
  • AbbVie$166
  • AstraZeneca$93
  • Aimmune Therapeutics, Inc.$73
  • plus $684 from 20 others

What the payments were for

  • Food & beverage$1,778100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,778 in reported general payments places this provider in the 75th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$60,494
Medicare patients
194
Services billed
1,257

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin188$215,972
EliquisApixaban61$68,743
TrulicityDulaglutide61$65,901
OzempicSemaglutide40$53,482
JanuviaSitagliptin Phosphate17$20,456
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$19,619
ShingrixVaricella-Zoster Ge/As01b/Pf61$13,727
Tresiba Flextouch U-100Insulin Degludec24$13,230
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr17$11,329
LinzessLinaclotide13$8,459
SymbicortBudesonide/Formoterol Fumarate32$7,196
FarxigaDapagliflozin Propanediol11$6,245
TradjentaLinagliptin11$5,684
Atorvastatin Calcium630$5,346
Humalog Kwikpen U-100Insulin Lispro20$4,392

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$61$221,656199 claims
PfizerEliquis$348$68,74361 claims
Lilly USA, LLCTrulicity$193$65,90161 claims
Novo NordiskOzempic$220$53,48240 claims
GSKTrelegy Ellipta, Shingrix, Anoro Ellipta$43$44,67593 claims
MerckJanuvia$64$20,45617 claims
AstraZenecaSymbicort, Farxiga$93$13,44143 claims
AbbVieLinzess$166$8,45913 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Durham

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →